Treatment of Adults with Lennox–Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide

INTRODUCTION: Management of Lennox–Gastaut syndrome (LGS) in adulthood can be particularly challenging. Published reports describing the use of rufinamide specifically in adult patients with LGS are scarce. A post hoc subgroup analysis of data from a phase III trial was conducted to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: McMurray, Rob, Striano, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919131/
https://www.ncbi.nlm.nih.gov/pubmed/26861566
http://dx.doi.org/10.1007/s40120-016-0041-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919131/
https://www.ncbi.nlm.nih.gov/pubmed/26861566
http://dx.doi.org/10.1007/s40120-016-0041-9

Ejemplares similares